Post-COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective

First Author: Currie, Last Author: G

"Technegas is in widespread use in Australia and offers a number of clear advantages over aerosols in the COVID19 patient. Technegas reduces the time for performing the ventilation and improves compliance which decreases the risk of room and staff contamination. The patient administration sets are single use, selfcontained and without recirculation, eliminating risk between patients."

J Nucl Med Technol 2020; 48(3): 234-240